Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2015 · 10-Q
Revenue$2.41M$2.41M−19.7% vs Q2 2014 Net Income-$2.00M-$2.00MN/M vs Q2 2014 EPS Diluted-$0.06-$0.06N/M vs Q2 2014 Gross Profit$1,288,061−28.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,243,396N/M Free Cash Flowderived-$1,258,681N/M Margins · derivedGross margin53.4%−6.4 pt vs Q2 2014
Operating margin-82.7%−87.1 pt vs Q2 2014
Net margin-83.0%
ended Jun 30, 2015 · filed Aug 14, 2015 · 45 d after period end